Winton Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-38,927
| Closed | -$244K | – | 1415 |
|
|
2021
Q3 | $244K | Sell |
38,927
-23,911
| -38% | -$150K | 0.01% | 1178 |
|
|
2021
Q2 | $376K | Sell |
62,838
-5,328
| -8% | -$31.9K | 0.02% | 1070 |
|
|
2021
Q1 | $431K | Sell |
68,166
-15,555
| -19% | -$98.4K | 0.02% | 964 |
|
|
2020
Q4 | $471K | Sell |
83,721
-155,141
| -65% | -$873K | 0.03% | 821 |
|
|
2020
Q3 | $1.39M | Sell |
238,862
-119,239
| -33% | -$694K | 0.05% | 677 |
|
|
2020
Q2 | $2.58M | Buy |
358,101
+90,175
| +34% | +$650K | 0.07% | 521 |
|
|
2020
Q1 | $1.25M | Sell |
267,926
-125,749
| -32% | -$589K | 0.03% | 711 |
|
|
2019
Q4 | $3.16M | Buy |
+393,675
| New | +$3.16M | 0.04% | 628 |
|
|
2019
Q2 | – | Sell |
-21,122
| Closed | -$210K | – | 1291 |
|
|
2019
Q1 | $210K | Buy |
+21,122
| New | +$210K | ﹤0.01% | 949 |
|